Dr. Nathan Starke Explains Peptides: The Tiny Molecules That Unlock Your Health’s Potential

By Your Health Magazine Press Releases

More Press Releases Articles

Dr. Nathan Starke Explains Peptides: The Tiny Molecules That Unlock Your Health’s Potential

You’ve probably seen the word “peptides” everywhere lately. But what are they, exactly? And why are they showing up at the center of a new wave of personalized medicine?

Dr. Nathan Starke has a clear answer to that question, and it’s part of why he built his private medical concierge, Starke Medical Group, the way he did.

“Peptides are very en vogue right now, and especially all the rage on every form of social media,” Dr. Nathan Starke says. “I don’t think I go eight to twelve hours without someone else talking about them, mentioning them, seeing them somewhere online.”

But for Dr. Starke, a fellowship-trained urologist and andrologist, peptides aren’t a trend to chase. “They’re a powerful clinical tool worth understanding honestly and without the bias and baseless claims often promoted by their online cheerleaders.” And understanding them starts at the beginning.

What Are Peptides?

A peptide is a short chain of amino acids. Amino acids are the building blocks of proteins, but while proteins are long, complex structures, peptides are shorter, typically containing between 2 and 50 amino acids. 

That smaller size matters: the body absorbs peptides more readily than larger protein molecules, and many peptides function specifically as chemical messages that tell the body to do something.

Your body already produces thousands of them. Some regulate blood sugar. Some govern immune response. Some signal tissue to repair after injury. Others control how hormones are released.

“Peptides are not completely foreign substances like many other drugs and pharmaceuticals often called ‘small molecules’,” Dr. Nathan Starke explains. “They’re small proteins, fundamental building blocks of life, that act as signaling molecules in your body. What peptide therapy often does is to supplement the proteins your body produces less of as you age, or with certain conditions, or even because of genetics.”

Insulin is a peptide, in fact something of “the original peptide”, first discovered and developed as a treatment for type 1 Diabetes in the 1920s. So is GLP-1, the compound behind the GLP-1 receptor agonists like Ozempic or Wegovy, which are themselves also peptides. When drugs you’ve heard of are peptides, it starts to make sense why medicine is paying close attention to the broader class.

How Does Peptide Therapy Work?

The goal of peptide therapy is to trigger specific biological responses that have become harder to produce on their own.

“Things like growth hormone release, tissue healing, improved body composition, sexual function, and cognitive clarity,” as Dr. Starke describes it.

That targeted approach is part of what makes peptides interesting. Traditional pharmaceutical treatments often work by blocking or suppressing something — a receptor, an enzyme, a pathway. Therapeutic peptides more often work with the body’s existing systems, nudging them toward function rather than overriding them.

Types of Peptides

Collagen Peptides: The most widely available and most studied. Collagen is the structural protein holding skin, cartilage, tendons, and bone together. As we age, the body produces less of it. Oral collagen peptides have been shown in randomized controlled trials to support skin elasticity, improve joint comfort, and help maintain bone mineral density. They’re available without a prescription and are among the safest peptide options because they function essentially as a food-derived supplement.

CJC-1295 and Ipamorelin: These two are often used together because they stimulate the pituitary gland to release growth hormone through two different pathways. CJC-1295 mimics growth hormone-releasing hormone; ipamorelin works through ghrelin receptors. Together, the effect is synergistic — producing the kind of natural, pulsatile growth hormone release the body generates on its own when younger. Men and women using this combination under medical supervision often report improvements in body composition, sleep quality, recovery from exercise, and energy. These are prescribed off-label; the evidence base is promising but still developing.

BPC-157 (Body Protection Compound 157): Derived from a protein found in human gastric juice, BPC-157 has drawn significant research interest, although human clinical evidence remains limited. Animal studies are compelling. Human clinical data remains limited, and its regulatory status in the U.S. has been changing. It should only be used under physician supervision.

PT-141 (Bremelanotide): One of the few peptides (apart from the GLP-1 agonists) with FDA approval. Unlike Viagra or Cialis, which improve blood flow, PT-141 works in the brain — acting on melanocortin receptors to directly influence arousal and desire. It was approved specifically for hypoactive sexual desire disorder, and physicians use it for both men and women dealing with changes in sexual function.

Tesamorelin: An FDA-approved growth hormone-releasing hormone analog with clinical trial data supporting its role in reducing visceral abdominal fat. One of the more evidence-backed options for metabolic concerns.

Sermorelin: An older secretagogue with a longer track record. Often a physician’s first choice for patients who want growth hormone support with a more established safety profile.

Why the Source of Your Care Matters

Here’s where Dr. Starke gets direct—and where his reasoning for building Starke Medical the way he did connects to this topic.

“What concerns me most is how often people source these compounds anonymously online from various pharmacies or so-called research chemical production places, and take these powerful medicines often with no medical oversight—and no way to know when to call someone if something feels off.”

The peptide space, he acknowledges, is moving fast — faster, in some places, than the clinical evidence. “It’s important to me, as a doctor and a scientist, to be honest about where the science stands. For most of the popular peptides, we don’t have the robust clinical evidence that we would want to fully establish benefits or characterize the risks.”

That honesty is not dismissal. “I’m not the least bit dismissive of peptide therapy. The key is that patients shouldn’t navigate it alone.”

At Starke Medical, patients have access to peptide protocols sourced from reputable compounding pharmacies, with baseline labs, clear therapeutic goals, and real follow-up—not a prescription handed over with no ongoing relationship. That structure can help patients receive appropriate monitoring, follow-up, and medical guidance throughout treatment.